The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer

被引：3

作者：

de Oliveira, Thiago Bueno ^{[1
]}

Fontes, Debora Maloni Nasti ^{[2
]}

Montella, Tatiane Caldas ^{[3
]}

Lewgoy, Jairo ^{[4
]}

Dutra, Carolina ^{[5
]}

Miola, Thais Manfrinato ^{[6
]}

机构：

[1] AC Camargo Canc Ctr, Med Oncol Dept, BR-01509001 Sao Paulo, Brazil

[2] AC Camargo Canc Ctr, Nurse Navigator Dept, BR-01509001 Sao Paulo, Brazil

[3] Oncoclinicas, Oncoclin, BR-22250905 Rio De Janeiro, Brazil

[4] Hosp Mae de Deus, Med Oncol Dept, BR-90880481 Porto Alegre, Brazil

[5] Med Oncol Dept, Clin Soma, BR-88020210 Florianopolis, Brazil

[6] AC Camargo Canc Ctr, Nutr Oncol Dept, BR-01509001 Sao Paulo, Brazil

来源：

CURRENT ONCOLOGY | 2024年 / 31卷 / 01期

关键词：

multidisciplinary teams; non-small-cell lung cancer; mapping review; chemoradiotherapy; adverse events; immune checkpoint inhibitors; ORAL NUTRITIONAL SUPPLEMENTS; MULTIDISCIPLINARY TEAM MEETINGS; FATTY-ACIDS AFFECT; REAL-WORLD DATA; CONCURRENT CHEMORADIOTHERAPY; CLINICAL-OUTCOMES; EICOSAPENTAENOIC ACID; THORACIC RADIATION; BODY-COMPOSITION; NURSE NAVIGATOR;

D O I：

10.3390/curroncol31010012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer is a major cause of cancer deaths worldwide. Non-small-cell lung cancer (NSCLC) represents most lung cancer cases, and approximately one-third of patients present with stage III disease at diagnosis. As multiple treatment plans can be adopted for these patients depending on tumor size and nodal staging, stage III NSCLC management is challenging. Over the past decades, multidisciplinary teams (MDTs) have been implemented in healthcare services to coordinate actions among the different health care professionals involved in cancer care. The aim of this review was to discuss real-world evidence of the impact of MDTs on stage III NSCLC management, survival, and quality of life. Here, we performed a literature review to investigate the role of nutrition and navigational nursing in NSCLC care and the influence of MDTs in the choice of treatment plans, including immunotherapy consolidation, and in the management of chemotherapy and radiotherapy-related adverse events. We also performed a mapping review to identify gaps in the implementation of cancer care MDTs in healthcare services around the world.

引用

页码：183 / 202

页数：20

共 128 条

[1] Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment [J].

Agbarya, Abed ;

Shalata, Walid ;

Addeo, Alfredo ;

Charpidou, Andriani ;

Cuppens, Kristof ;

Brustugun, Odd Terje ;

Rajer, Mirjana ;

Jakopovic, Marco ;

Marinca, Mihai, V ;

Pluzanski, Adam ;

Hiltermann, Jeroen ;

Araujo, Antonio .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)

[2] Concurrent cisplatin, etoposide, and chest radiotherapy in Pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group Phase II Study, SWOG 9019 [J].

Albain, KS ;

Crowley, JJ ;

Turrisi, AT ;

Gandara, DR ;

Farrar, WB ;

Clark, JI ;

Beasley, KR ;

Livingston, RB .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) :3454-3460

[3] The Effect of a Lung Cancer Care Coordination Program on Timeliness of Care [J].

Alsamarai, Susan ;

Yao, Xiaopan ;

Cain, Hilary C. ;

Chang, Bryan W. ;

Chao, Herta H. ;

Connery, Donna M. ;

Deng, Yanhong ;

Garla, Vijay N. ;

Hunnibell, Laura S. ;

Kim, Anthony W. ;

Obando, J. Antonio ;

Taylor, Caroline ;

Tellides, George ;

Rose, Michal G. .

CLINICAL LUNG CANCER, 2013, 14 (05) :527-534

[4] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Yokoi, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

de Castro Carpeno, J. ;

Wadsworth, C. ;

Melillo, G. ;

Jiang, H. ;

Huang, Y. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) :1919-1929

[5] Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].

Auperin, Anne ;

Le Pechoux, Cecile ;

Rolland, Estelle ;

Curran, Walter J. ;

Furuse, Kiyoyuki ;

Fournel, Pierre ;

Belderbos, Jose ;

Clamon, Gerald ;

Ulutin, Hakki Cuneyt ;

Paulus, Rebecca ;

Yamanaka, Takeharu ;

Bozonnat, Marie-Cecile ;

Uitterhoeve, Apollonia ;

Wang, Xiaofei ;

Stewart, Lesley ;

Arriagada, Rodrigo ;

Burdett, Sarah ;

Pignon, Jean-Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2181-2190

[6] Radiation-induced esophagitis in lung cancer [J].

Baker, Sarah ;

Fairchild, Alysa .

LUNG CANCER-TARGETS AND THERAPY, 2016, 7 :119-127

[7] Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis [J].

Baracos, Vickie E. ;

Reiman, Tony ;

Mourtzakis, Marina ;

Gioulbasanis, Ioannis ;

Antoun, Sami .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (04) :1133S-1137S

[8] Real-World Experience of Consolidation Durvalumab for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [J].

Barbaro, A. ;

Mienko, F. ;

Deng, L. ;

Ohri, N. ;

Halmos, B. ;

Perez-Soler, R. ;

Gucalp, R. ;

Bodner, W. ;

Cheng, H. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S906-S907

[9] Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol [J].

Belani, CP ;

Choy, H ;

Bonomi, P ;

Scott, C ;

Travis, P ;

Haluschak, J ;

Curran, WJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5883-5891

[10] Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach [J].

Bilfinger, Thomas V. ;

Albano, Denise ;

Perwaiz, Muhammed ;

Keresztes, Roger ;

Nemesure, Barbara .

CLINICAL LUNG CANCER, 2018, 19 (04) :346-351

← 1 2 3 4 5 6 7 8 9 10 →